Two cases of advanced and metastatic breast cancers treated by docetaxel in combination with intra-arterial infusion of adriamycin

H. Doihara, S. Yoshitomi, M. Hino, A. Teramoto, Y. Ishibe, Y. Ogasawara, I. Nagahiro, Y. Sano, N. Shimizu

Research output: Contribution to journalArticlepeer-review

Abstract

Two cases of advanced and metastatic breast cancers were treated by docetaxel (TXT) in combination with intra-arterial infusion of adriamycin (ADM). Patients received 60 mg/body TXT i.v. and 30 mg/body ADM ia (AT therapy) bi-weekly. Clinical responses were observed in these two patients and the durations of responses were over 20 weeks. Critical toxicities of grade 2 leukopenia and alopecia were observed but grade 4 severe toxicities were not. Thus AT therapy can be easily and safely performed with outpatients. This therapy can improve the response rate and time to progression; therefore phase I or phase I/II clinical trials of AT therapy in Japan are recommended.

Original languageEnglish
Pages (from-to)229-233
Number of pages5
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume28
Issue number2
Publication statusPublished - Feb 2001

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Two cases of advanced and metastatic breast cancers treated by docetaxel in combination with intra-arterial infusion of adriamycin'. Together they form a unique fingerprint.

Cite this